the coronavirus
The pandemic has changed the way we buy and today, the most demanded product in the world market is the coronavirus vaccine. After months of work and hard work by scientists around the world, people finally breathe a sigh of relief with multiple COVID-19 vaccines that have successfully passed the testing phase.
While Pfizer-BioNtech and Moderna’s coronavirus Vaccines have claimed over 90 percent effectiveness, the recently tested Oxford-AstraZeneca vaccine recently showed 70 percent effectiveness in Phase 3 testing.
As good news as it may be, none of the vaccines have been tested with 100% success and new advances are being made every day. For some companies and marketers, however, coronavirus The vaccine has been not only a blessing to save human lives, but also a tool to extract money from naive people.
After 1.4 million deaths worldwide, people are desperate for a vaccine. And some marketers are taking advantage of people’s vulnerabilities and concerns with a strange new trend that many now call “vaccine tourism.”
On Monday, Edelweiss Mutual Funds CEO Radhika Gupta took to Twitter to share a screenshot of a WhatsApp message that has been circulating. The message appeared to have come from a travel company that was offering a rather lucrative and forward-thinking package tour to the United States in December, as soon as the Pfizer vaccine hits the US market. The three-day, four-night package from Mumbai to New York and then back to Mumbai would cost you Rs 1,74,999, which includes the air show and hotel stay.
As macabre and insensitive as it may be, the ad is not surprising. With the coronavirus Vaccine has become the most sought after product that has yet to arrive in 2020, the world is full of excitement and anticipation. But while developing a vaccine was primarily the role of the scientific community, ensuring its equitable distribution to all people in countries and the world is the role of world governments and civil society.
India has also been testing vaccines at home, and at least five candidate vaccines are undergoing human trials. On Tuesday, India’s Health Minister Harsh Vardhan claimed that India might not need the Pfizer vaccine at all, as several Indian contenders such as Covaxin, Zy-CovD await the results of phase 2 of the trial.
.
